nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextrothyroxine—SLC7A5—Melphalan—peripheral nervous system neoplasm	0.831	1	CbGbCtD
Dextrothyroxine—TPO—Hematopoietic Stem Cell Differentiation—MXI1—peripheral nervous system neoplasm	0.00446	0.189	CbGpPWpGaD
Dextrothyroxine—TPO—Differentiation Pathway—ALK—peripheral nervous system neoplasm	0.00308	0.131	CbGpPWpGaD
Dextrothyroxine—TPO—Amine-derived hormones—TH—peripheral nervous system neoplasm	0.00245	0.104	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00146	0.0621	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.181	CbGdCrCtD
Dextrothyroxine—SLC7A5—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.0012	0.181	CbGdCrCtD
Dextrothyroxine—SLC7A5—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.0012	0.181	CbGdCrCtD
Dextrothyroxine—SLC7A5—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.181	CbGdCrCtD
Dextrothyroxine—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000985	0.0418	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000913	0.137	CbGdCrCtD
Dextrothyroxine—SLC7A5—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000913	0.137	CbGdCrCtD
Dextrothyroxine—Levothyroxine—ABCB1—peripheral nervous system neoplasm	0.000843	0.372	CrCbGaD
Dextrothyroxine—SLCO1B1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000836	0.0355	CbGpPWpGaD
Dextrothyroxine—Liotrix—ABCB1—peripheral nervous system neoplasm	0.000823	0.363	CrCbGaD
Dextrothyroxine—TPO—Differentiation Pathway—HGF—peripheral nervous system neoplasm	0.000791	0.0336	CbGpPWpGaD
Dextrothyroxine—Liothyronine—ABCB1—peripheral nervous system neoplasm	0.000601	0.265	CrCbGaD
Dextrothyroxine—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000539	0.0229	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000421	0.0179	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000385	0.0164	CbGpPWpGaD
Dextrothyroxine—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000378	0.00277	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000368	0.0027	CcSEcCtD
Dextrothyroxine—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.000367	0.00269	CcSEcCtD
Dextrothyroxine—Tension—Alitretinoin—peripheral nervous system neoplasm	0.000365	0.00268	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000365	0.00268	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000365	0.00268	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.000364	0.00267	CcSEcCtD
Dextrothyroxine—Alopecia—Vincristine—peripheral nervous system neoplasm	0.000364	0.00267	CcSEcCtD
Dextrothyroxine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000363	0.00266	CcSEcCtD
Dextrothyroxine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000363	0.00266	CcSEcCtD
Dextrothyroxine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000362	0.00265	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000361	0.00264	CcSEcCtD
Dextrothyroxine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00036	0.00264	CcSEcCtD
Dextrothyroxine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000357	0.00262	CcSEcCtD
Dextrothyroxine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000357	0.00262	CcSEcCtD
Dextrothyroxine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000353	0.00259	CcSEcCtD
Dextrothyroxine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000349	0.00256	CcSEcCtD
Dextrothyroxine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000348	0.00255	CcSEcCtD
Dextrothyroxine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000346	0.00253	CcSEcCtD
Dextrothyroxine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000346	0.00253	CcSEcCtD
Dextrothyroxine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00251	CcSEcCtD
Dextrothyroxine—TPO—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.000341	0.0145	CbGpPWpGaD
Dextrothyroxine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000341	0.0025	CcSEcCtD
Dextrothyroxine—Coma—Epirubicin—peripheral nervous system neoplasm	0.00034	0.0025	CcSEcCtD
Dextrothyroxine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000338	0.00248	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000333	0.00244	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00033	0.00242	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00033	0.00242	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00033	0.00242	CcSEcCtD
Dextrothyroxine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00033	0.00242	CcSEcCtD
Dextrothyroxine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.00241	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000328	0.0024	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000328	0.0024	CcSEcCtD
Dextrothyroxine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000326	0.00239	CcSEcCtD
Dextrothyroxine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.00236	CcSEcCtD
Dextrothyroxine—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000322	0.00236	CcSEcCtD
Dextrothyroxine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000321	0.00235	CcSEcCtD
Dextrothyroxine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000319	0.00234	CcSEcCtD
Dextrothyroxine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000319	0.00234	CcSEcCtD
Dextrothyroxine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000318	0.00233	CcSEcCtD
Dextrothyroxine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000318	0.00233	CcSEcCtD
Dextrothyroxine—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000317	0.00232	CcSEcCtD
Dextrothyroxine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000317	0.00232	CcSEcCtD
Dextrothyroxine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000317	0.00232	CcSEcCtD
Dextrothyroxine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000317	0.00232	CcSEcCtD
Dextrothyroxine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000317	0.00232	CcSEcCtD
Dextrothyroxine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000316	0.00231	CcSEcCtD
Dextrothyroxine—Coma—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.00231	CcSEcCtD
Dextrothyroxine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000314	0.0023	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000314	0.0133	CbGpPWpGaD
Dextrothyroxine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000311	0.00228	CcSEcCtD
Dextrothyroxine—Flushing—Etoposide—peripheral nervous system neoplasm	0.00031	0.00227	CcSEcCtD
Dextrothyroxine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.00225	CcSEcCtD
Dextrothyroxine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00219	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000299	0.00219	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.000298	0.00219	CcSEcCtD
Dextrothyroxine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000297	0.00218	CcSEcCtD
Dextrothyroxine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000297	0.00217	CcSEcCtD
Dextrothyroxine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000295	0.00216	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.00215	CcSEcCtD
Dextrothyroxine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00029	0.00213	CcSEcCtD
Dextrothyroxine—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000288	0.00211	CcSEcCtD
Dextrothyroxine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000288	0.00211	CcSEcCtD
Dextrothyroxine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000288	0.00211	CcSEcCtD
Dextrothyroxine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000286	0.0021	CcSEcCtD
Dextrothyroxine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000284	0.00208	CcSEcCtD
Dextrothyroxine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000284	0.00208	CcSEcCtD
Dextrothyroxine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000284	0.00208	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000283	0.00207	CcSEcCtD
Dextrothyroxine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000283	0.00207	CcSEcCtD
Dextrothyroxine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00028	0.00205	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000277	0.00203	CcSEcCtD
Dextrothyroxine—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000277	0.00203	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.00203	CcSEcCtD
Dextrothyroxine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000277	0.00203	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.00202	CcSEcCtD
Dextrothyroxine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000275	0.00201	CcSEcCtD
Dextrothyroxine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.00201	CcSEcCtD
Dextrothyroxine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000274	0.00201	CcSEcCtD
Dextrothyroxine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000274	0.00201	CcSEcCtD
Dextrothyroxine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.00199	CcSEcCtD
Dextrothyroxine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000271	0.00198	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00027	0.00198	CcSEcCtD
Dextrothyroxine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000269	0.00197	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000268	0.00196	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—PTPN11—peripheral nervous system neoplasm	0.000267	0.0114	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000267	0.00195	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000267	0.0113	CbGpPWpGaD
Dextrothyroxine—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.00195	CcSEcCtD
Dextrothyroxine—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000266	0.00195	CcSEcCtD
Dextrothyroxine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000265	0.00194	CcSEcCtD
Dextrothyroxine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.00192	CcSEcCtD
Dextrothyroxine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000259	0.0019	CcSEcCtD
Dextrothyroxine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000259	0.0019	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000257	0.00189	CcSEcCtD
Dextrothyroxine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000257	0.00188	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.00188	CcSEcCtD
Dextrothyroxine—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.00188	CcSEcCtD
Dextrothyroxine—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000256	0.00188	CcSEcCtD
Dextrothyroxine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000255	0.00187	CcSEcCtD
Dextrothyroxine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000255	0.00187	CcSEcCtD
Dextrothyroxine—Rash—Topotecan—peripheral nervous system neoplasm	0.000255	0.00187	CcSEcCtD
Dextrothyroxine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000255	0.00187	CcSEcCtD
Dextrothyroxine—Headache—Topotecan—peripheral nervous system neoplasm	0.000253	0.00186	CcSEcCtD
Dextrothyroxine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000253	0.00185	CcSEcCtD
Dextrothyroxine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000253	0.00185	CcSEcCtD
Dextrothyroxine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000253	0.00185	CcSEcCtD
Dextrothyroxine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000253	0.00185	CcSEcCtD
Dextrothyroxine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000253	0.00185	CcSEcCtD
Dextrothyroxine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000252	0.00185	CcSEcCtD
Dextrothyroxine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000252	0.00185	CcSEcCtD
Dextrothyroxine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000252	0.00184	CcSEcCtD
Dextrothyroxine—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000252	0.00184	CcSEcCtD
Dextrothyroxine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000251	0.00184	CcSEcCtD
Dextrothyroxine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000251	0.00184	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.00183	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00025	0.00183	CcSEcCtD
Dextrothyroxine—Rash—Melphalan—peripheral nervous system neoplasm	0.00025	0.00183	CcSEcCtD
Dextrothyroxine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000249	0.00183	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000248	0.00182	CcSEcCtD
Dextrothyroxine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.00181	CcSEcCtD
Dextrothyroxine—SLCO4A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000242	0.0103	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000242	0.0103	CbGpPWpGaD
Dextrothyroxine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.00177	CcSEcCtD
Dextrothyroxine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.00176	CcSEcCtD
Dextrothyroxine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.00176	CcSEcCtD
Dextrothyroxine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00024	0.00176	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000239	0.00175	CcSEcCtD
Dextrothyroxine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000239	0.00175	CcSEcCtD
Dextrothyroxine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000239	0.00175	CcSEcCtD
Dextrothyroxine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000238	0.00175	CcSEcCtD
Dextrothyroxine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000238	0.00175	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.00174	CcSEcCtD
Dextrothyroxine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.00174	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000236	0.00173	CcSEcCtD
Dextrothyroxine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000235	0.00172	CcSEcCtD
Dextrothyroxine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000235	0.00172	CcSEcCtD
Dextrothyroxine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000234	0.00171	CcSEcCtD
Dextrothyroxine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.00171	CcSEcCtD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000232	0.00985	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000232	0.00985	CbGpPWpGaD
Dextrothyroxine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000231	0.0017	CcSEcCtD
Dextrothyroxine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000231	0.0017	CcSEcCtD
Dextrothyroxine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000231	0.0017	CcSEcCtD
Dextrothyroxine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000231	0.00169	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000229	0.00168	CcSEcCtD
Dextrothyroxine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000228	0.00167	CcSEcCtD
Dextrothyroxine—THRB—Gene Expression—EED—peripheral nervous system neoplasm	0.000225	0.00957	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—EED—peripheral nervous system neoplasm	0.000225	0.00957	CbGpPWpGaD
Dextrothyroxine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000224	0.00164	CcSEcCtD
Dextrothyroxine—SLC7A5—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000221	0.00938	CbGpPWpGaD
Dextrothyroxine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00162	CcSEcCtD
Dextrothyroxine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.0016	CcSEcCtD
Dextrothyroxine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00159	CcSEcCtD
Dextrothyroxine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.00158	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000213	0.00156	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000212	0.00901	CbGpPWpGaD
Dextrothyroxine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00155	CcSEcCtD
Dextrothyroxine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000211	0.00155	CcSEcCtD
Dextrothyroxine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.00154	CcSEcCtD
Dextrothyroxine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00021	0.00154	CcSEcCtD
Dextrothyroxine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000208	0.00153	CcSEcCtD
Dextrothyroxine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000208	0.00152	CcSEcCtD
Dextrothyroxine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000207	0.00151	CcSEcCtD
Dextrothyroxine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000205	0.0015	CcSEcCtD
Dextrothyroxine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000204	0.0015	CcSEcCtD
Dextrothyroxine—SLCO1C1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000202	0.0086	CbGpPWpGaD
Dextrothyroxine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.0002	0.00147	CcSEcCtD
Dextrothyroxine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00146	CcSEcCtD
Dextrothyroxine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.00143	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000195	0.00143	CcSEcCtD
Dextrothyroxine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000195	0.00143	CcSEcCtD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000194	0.00825	CbGpPWpGaD
Dextrothyroxine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000194	0.00142	CcSEcCtD
Dextrothyroxine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00142	CcSEcCtD
Dextrothyroxine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.0014	CcSEcCtD
Dextrothyroxine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.0014	CcSEcCtD
Dextrothyroxine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00019	0.0014	CcSEcCtD
Dextrothyroxine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000188	0.00138	CcSEcCtD
Dextrothyroxine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000187	0.00137	CcSEcCtD
Dextrothyroxine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000187	0.00137	CcSEcCtD
Dextrothyroxine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000186	0.00136	CcSEcCtD
Dextrothyroxine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000186	0.00136	CcSEcCtD
Dextrothyroxine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00136	CcSEcCtD
Dextrothyroxine—Rash—Vincristine—peripheral nervous system neoplasm	0.000185	0.00135	CcSEcCtD
Dextrothyroxine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000184	0.00135	CcSEcCtD
Dextrothyroxine—Headache—Vincristine—peripheral nervous system neoplasm	0.000183	0.00134	CcSEcCtD
Dextrothyroxine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00018	0.00132	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.00018	0.00765	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.00018	0.00765	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00018	0.00765	CbGpPWpGaD
Dextrothyroxine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000177	0.0013	CcSEcCtD
Dextrothyroxine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000174	0.00127	CcSEcCtD
Dextrothyroxine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00127	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—AKT1—peripheral nervous system neoplasm	0.000173	0.00735	CbGpPWpGaD
Dextrothyroxine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00017	0.00125	CcSEcCtD
Dextrothyroxine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000168	0.00123	CcSEcCtD
Dextrothyroxine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00123	CcSEcCtD
Dextrothyroxine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00121	CcSEcCtD
Dextrothyroxine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000165	0.00121	CcSEcCtD
Dextrothyroxine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000163	0.0012	CcSEcCtD
Dextrothyroxine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000163	0.0012	CcSEcCtD
Dextrothyroxine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000162	0.00119	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	0.000161	0.00683	CbGpPWpGaD
Dextrothyroxine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00118	CcSEcCtD
Dextrothyroxine—Tension—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00117	CcSEcCtD
Dextrothyroxine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00116	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000157	0.00666	CbGpPWpGaD
Dextrothyroxine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.00113	CcSEcCtD
Dextrothyroxine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000154	0.00113	CcSEcCtD
Dextrothyroxine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00112	CcSEcCtD
Dextrothyroxine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000151	0.00111	CcSEcCtD
Dextrothyroxine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00015	0.0011	CcSEcCtD
Dextrothyroxine—Rash—Etoposide—peripheral nervous system neoplasm	0.00015	0.0011	CcSEcCtD
Dextrothyroxine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000149	0.00109	CcSEcCtD
Dextrothyroxine—Headache—Etoposide—peripheral nervous system neoplasm	0.000149	0.00109	CcSEcCtD
Dextrothyroxine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00108	CcSEcCtD
Dextrothyroxine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00107	CcSEcCtD
Dextrothyroxine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000144	0.00106	CcSEcCtD
Dextrothyroxine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00103	CcSEcCtD
Dextrothyroxine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000141	0.00103	CcSEcCtD
Dextrothyroxine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.00102	CcSEcCtD
Dextrothyroxine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00102	CcSEcCtD
Dextrothyroxine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00101	CcSEcCtD
Dextrothyroxine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000982	CcSEcCtD
Dextrothyroxine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000976	CcSEcCtD
Dextrothyroxine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000959	CcSEcCtD
Dextrothyroxine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000957	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—GNS—peripheral nervous system neoplasm	0.00013	0.00553	CbGpPWpGaD
Dextrothyroxine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000951	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000129	0.00547	CbGpPWpGaD
Dextrothyroxine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000942	CcSEcCtD
Dextrothyroxine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00094	CcSEcCtD
Dextrothyroxine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000937	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—NME1—peripheral nervous system neoplasm	0.000125	0.0053	CbGpPWpGaD
Dextrothyroxine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000909	CcSEcCtD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000123	0.00521	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000123	0.00521	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000888	CcSEcCtD
Dextrothyroxine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000887	CcSEcCtD
Dextrothyroxine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000881	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—COX2—peripheral nervous system neoplasm	0.00012	0.0051	CbGpPWpGaD
Dextrothyroxine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.00088	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000119	0.00507	CbGpPWpGaD
Dextrothyroxine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000872	CcSEcCtD
Dextrothyroxine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000869	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	0.000118	0.005	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000117	0.00495	CbGpPWpGaD
Dextrothyroxine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00084	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000112	0.00477	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000821	CcSEcCtD
Dextrothyroxine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000815	CcSEcCtD
Dextrothyroxine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000804	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000803	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000797	CcSEcCtD
Dextrothyroxine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000777	CcSEcCtD
Dextrothyroxine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000774	CcSEcCtD
Dextrothyroxine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000105	0.00077	CcSEcCtD
Dextrothyroxine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000105	0.00077	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000104	0.00443	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000103	0.00437	CbGpPWpGaD
Dextrothyroxine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000743	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000737	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—HGF—peripheral nervous system neoplasm	9.94e-05	0.00422	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.88e-05	0.00419	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.88e-05	0.00419	CbGpPWpGaD
Dextrothyroxine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.000716	CcSEcCtD
Dextrothyroxine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000713	CcSEcCtD
Dextrothyroxine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000713	CcSEcCtD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.69e-05	0.00412	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.69e-05	0.00412	CbGpPWpGaD
Dextrothyroxine—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.54e-05	0.000699	CcSEcCtD
Dextrothyroxine—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.41e-05	0.000689	CcSEcCtD
Dextrothyroxine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000667	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.03e-05	0.00384	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.86e-05	0.00376	CbGpPWpGaD
Dextrothyroxine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000647	CcSEcCtD
Dextrothyroxine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.7e-05	0.000638	CcSEcCtD
Dextrothyroxine—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.45e-05	0.000619	CcSEcCtD
Dextrothyroxine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000617	CcSEcCtD
Dextrothyroxine—Rash—Epirubicin—peripheral nervous system neoplasm	8.38e-05	0.000614	CcSEcCtD
Dextrothyroxine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.37e-05	0.000614	CcSEcCtD
Dextrothyroxine—Headache—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.00061	CcSEcCtD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.28e-05	0.00351	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.12e-05	0.00345	CbGpPWpGaD
Dextrothyroxine—Nausea—Epirubicin—peripheral nervous system neoplasm	7.9e-05	0.000579	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—ENO2—peripheral nervous system neoplasm	7.89e-05	0.00335	CbGpPWpGaD
Dextrothyroxine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.82e-05	0.000573	CcSEcCtD
Dextrothyroxine—Rash—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000568	CcSEcCtD
Dextrothyroxine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.75e-05	0.000568	CcSEcCtD
Dextrothyroxine—Headache—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000565	CcSEcCtD
Dextrothyroxine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	7.7e-05	0.00327	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.69e-05	0.00326	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.4e-05	0.00314	CbGpPWpGaD
Dextrothyroxine—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.31e-05	0.000535	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—PTPN11—peripheral nervous system neoplasm	7.25e-05	0.00308	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—BCHE—peripheral nervous system neoplasm	6.66e-05	0.00283	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.36e-05	0.0027	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—TH—peripheral nervous system neoplasm	6.26e-05	0.00266	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.19e-05	0.0022	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	5.17e-05	0.0022	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	5.17e-05	0.0022	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—GNAS—peripheral nervous system neoplasm	5.11e-05	0.00217	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—ABCB1—peripheral nervous system neoplasm	5.02e-05	0.00213	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—NRAS—peripheral nervous system neoplasm	4.36e-05	0.00185	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.31e-05	0.00183	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.91e-05	0.00166	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	3.75e-05	0.00159	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	3.6e-05	0.00153	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	3.46e-05	0.00147	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—TP53—peripheral nervous system neoplasm	3.34e-05	0.00142	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—HRAS—peripheral nervous system neoplasm	3.19e-05	0.00135	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.15e-05	0.00134	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.09e-05	0.00131	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—AKT1—peripheral nervous system neoplasm	2.82e-05	0.0012	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—MYC—peripheral nervous system neoplasm	2.49e-05	0.00106	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—MYC—peripheral nervous system neoplasm	2.49e-05	0.00106	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	2.27e-05	0.000966	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.92e-05	0.000816	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.83e-05	0.000779	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	1.81e-05	0.000767	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—AKT1—peripheral nervous system neoplasm	1.73e-05	0.000733	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—AKT1—peripheral nervous system neoplasm	1.73e-05	0.000733	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.47e-05	0.000626	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.45e-05	0.000615	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000586	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	3.98e-06	0.000169	CbGpPWpGaD
